Opportunity Information: Apply for CDC RFA PS09 93704CONT12
Apply for CDC RFA PS09 93704CONT12
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Medical Monitoring Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.944 Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance.
- This funding opportunity was created on Feb 3, 2012 and posted on Jan 30, 2012.
- Applicants must submit their applications by Mar 19, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under PS09 937 Medical Monitoring Project.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Medical Monitoring Project grant opportunity (Funding Opportunity Number CDC RFA PS09-93704CONT12) is a Centers for Disease Control and Prevention (CDC) continuation cooperative agreement focused on HIV/AIDS surveillance activities under CFDA 93.944, Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance. It was posted on January 30, 2012, created on February 3, 2012, and had an application closing date of March 19, 2012, with the opportunity later archived on April 18, 2012. The CDC anticipated making up to 10 awards under this continuation announcement, and there is no cost sharing or matching requirement tied to participation.
This announcement is not an open competition for new organizations. Eligibility is restricted to entities that had already been funded under the earlier Medical Monitoring Project award (PS09-937). In other words, the continuation funds were intended only for existing grantees to maintain and carry forward work already underway, rather than to launch brand-new projects by first-time applicants. The opportunity category is explicitly labeled as continuation, and the instrument type is a cooperative agreement, which typically indicates that the CDC expects substantial involvement in the funded work (such as ongoing technical guidance, coordination, and collaboration) compared with a standard grant.
The stated purpose of the announcement is administrative and programmatic guidance: it provides instructions for preparing an interim progress report for the Medical Monitoring Project. While the brief synopsis does not list detailed reporting elements, an interim progress report in this kind of surveillance-focused cooperative agreement generally serves to document what has been accomplished so far, assess performance against approved objectives and timelines, describe any challenges or barriers affecting implementation, explain corrective actions, and outline planned activities for the next reporting period. Because the program is categorized under HIV/AIDS surveillance, the reporting would reasonably be expected to emphasize progress in collecting, managing, and submitting surveillance-related information, adherence to any applicable protocols or standards, and the status of activities that support monitoring the experiences and outcomes of people receiving HIV-related care.
For applicants (which in this case means current grantees), the practical takeaway is that this continuation notice functions as a formal vehicle for continued funding tied to satisfactory progress and compliance with reporting requirements. The interim progress report is the key deliverable referenced, and it would be central to demonstrating that the recipient is meeting expectations under the existing cooperative agreement and remains on track to fulfill the public health surveillance goals of the Medical Monitoring Project.
For help with access to the full announcement, the CDC provided a point of contact through CDC PGOTIMS at 770-488-2700 or by email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the Medical Monitoring Project grant opportunity?
This opportunity is a CDC continuation cooperative agreement for HIV/AIDS surveillance activities under the Medical Monitoring Project (MMP). It is identified as Funding Opportunity Number CDC RFA PS09-93704CONT12 and is associated with CFDA 93.944, Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance.
Who is the funding agency for this opportunity?
The funding agency is the Centers for Disease Control and Prevention (CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS09-93704CONT12.
Is this an open competition for new applicants?
No. This announcement is not an open competition for new organizations. It is explicitly a continuation opportunity and is restricted to entities that were already funded under the earlier Medical Monitoring Project award PS09-937.
Who is eligible to apply?
Eligibility is limited to current/previous recipients funded under the earlier Medical Monitoring Project award PS09-937. The continuation funds are intended for existing grantees to continue work already underway.
What type of funding instrument is being used?
The instrument type is a cooperative agreement.
What does it mean that this is a cooperative agreement?
Based on the description provided, a cooperative agreement typically indicates substantial CDC involvement in the funded work, such as ongoing technical guidance, coordination, and collaboration, compared with a standard grant.
What is the opportunity category?
The opportunity category is continuation.
How many awards did the CDC anticipate making?
The CDC anticipated making up to 10 awards under this continuation announcement.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement tied to participation in this opportunity.
What is the stated purpose of this continuation announcement?
The stated purpose is to provide administrative and programmatic guidance, including instructions for preparing an interim progress report for the Medical Monitoring Project.
What is the key deliverable referenced in the announcement?
The key deliverable referenced is an interim progress report.
What is an interim progress report expected to cover for a surveillance-focused cooperative agreement like this?
While the synopsis does not list detailed reporting elements, the description indicates that an interim progress report in this context generally documents accomplishments to date, assesses performance against approved objectives and timelines, describes challenges or barriers affecting implementation, explains corrective actions, and outlines planned activities for the next reporting period.
How does the HIV/AIDS surveillance focus affect what might be emphasized in reporting?
Because the program is categorized under HIV/AIDS surveillance, the report would reasonably be expected to emphasize progress related to collecting, managing, and submitting surveillance-related information, adherence to applicable protocols or standards, and the status of activities that support monitoring the experiences and outcomes of people receiving HIV-related care.
What is the practical takeaway for current grantees?
The continuation notice serves as the formal vehicle for continued funding tied to satisfactory progress and compliance with reporting requirements. The interim progress report is central to demonstrating that the recipient is meeting expectations under the existing cooperative agreement and remains on track to fulfill the public health surveillance goals of the Medical Monitoring Project.
When was the opportunity posted?
The opportunity was posted on January 30, 2012.
When was the opportunity created?
The opportunity was created on February 3, 2012.
What was the application closing date?
The application closing date was March 19, 2012.
When was the opportunity archived?
The opportunity was archived on April 18, 2012.
Which CFDA program is associated with this funding?
This funding is associated with CFDA 93.944, Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance.
Where can someone get help accessing the full announcement?
For help with access to the full announcement, the CDC provided a point of contact through CDC PGOTIMS at 770-488-2700 or by email at pgotim@cdc.gov.
Does the synopsis describe detailed reporting elements for the interim progress report?
No. The synopsis does not list detailed reporting elements, but it indicates the interim progress report generally serves to document progress, performance, challenges, corrective actions, and planned next steps.
Is this continuation funding intended to launch brand-new projects?
No. The continuation funds were intended only for existing grantees to maintain and carry forward work already underway, rather than to launch brand-new projects by first-time applicants.
Browse more opportunities from the same category: Health
Next opportunity: U.S. Embassy Kabul Public Affairs Section, Local Grants Program
Previous opportunity: R2 Wildlife Restoration Grant Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 93704CONT12
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 93704CONT12) also looked into and applied for these:
| Funding Opportunity |
|---|
| Marketing Innovation For Health Apply for RFA 388 12 000001 Funding Number: RFA 388 12 000001 Agency: Bangladesh USAID Dhaka Category: Health Funding Amount: $15,000,000 |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Coordinating and Statistical Centers (U01) Apply for RFA NS 13 001 Funding Number: RFA NS 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10) Apply for RFA NS 13 002 Funding Number: RFA NS 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24 Apply for RFA AA 12 010 Funding Number: RFA AA 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Strengthening Federal Coordination and Monitoring and Evaluation of the Multi Sectoral response to HIV/AIDS in Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH12 1220 Funding Number: CDC RFA GH12 1220 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,050,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 12 087 Funding Number: PAR 12 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening of the National External Quality Assessment (EQA) Program through Establishment and Implementation of an Efficient Distribution and Analysis of Proficiency Materials for Human Immunodeficiency Virus (HIV), Tuberculosis, and Opportunisti Apply for CDC RFA GH12 1234 Funding Number: CDC RFA GH12 1234 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Partnerships for Development of Vaccine Technologies (R01) Apply for RFA AI 12 014 Funding Number: RFA AI 12 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Access for the Bridging Interventional Development Gaps Program (X01) Apply for PAR 12 092 Funding Number: PAR 12 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NU HITES Apply for RFA 617 12 000005 Funding Number: RFA 617 12 000005 Agency: Uganda USAID Kampala Category: Health Funding Amount: $50,000,000 |
| Strengthening Systems, Capacity, and Data Collection with a Focus on Strategic Information in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1256 Funding Number: CDC RFA GH12 1256 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Engaging Local Indigenous Organizations in Improving Quality and Efficiency of HIV Care and Treatment Services in Ukraine under the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1227 Funding Number: CDC RFA GH12 1227 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1205 Funding Number: CDC RFA GH12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 12 001 Funding Number: CMS 1LI 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Expanding Participation of People with Disabilities in USAID Activities andStrengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 12 000002 Funding Number: RFA 114 12 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Implementation of a Program to Build the Institutional Apply for CDC RFA GH12 1243 Funding Number: CDC RFA GH12 1243 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,130,000 |
| Modeling Social Behavior (R01) Apply for RFA GM 13 006 Funding Number: RFA GM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grand Challenges in Global Mental Health Integrating Mental Health into Chronic Disease Care Provision in Low and Middle Income Countries (R01) Apply for RFA MH 13 040 Funding Number: RFA MH 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Increasing Human Resources for Health and Epidemiological Capacity in the Republic of Guyana through a University Training Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1208 Funding Number: CDC RFA GH12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $440,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 12 003 Funding Number: SP 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 93704CONT12", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.